» Articles » PMID: 36969216

TOX Regulates T Lymphocytes Differentiation and Its Function in Tumor

Overview
Journal Front Immunol
Date 2023 Mar 27
PMID 36969216
Authors
Affiliations
Soon will be listed here.
Abstract

Thymocyte selection-associated high mobility group box protein (TOX) is expressed differently at all T lymphocytes development stages. Owing to more advanced scientific and technological means, including single-cell sequencing technology, heterogeneity of T lymphocytes and TOX has gradually been revealed. Further exploration of such heterogeneity will help us comprehend the developmental stage and functional characteristics of T lymphocytes in greater detail. Emerging evidence supports its regulation not only in exhausting, but also in activating T lymphocytes, thereby verifying TOX heterogeneity. TOX can be used not only as a latent intervention target for tumor diseases and chronic infections, and a therapeutic strategy for autoimmune diseases, but also as a critical factor predicting the drug response and overall survival of patients with malignant tumors.

Citing Articles

Population structure and selective signature analysis of local sheep breeds in Xinjiang, China based on high-density SNP chip.

Li Y, Li X, Han Z, Yang R, Zhou W, Peng Y Sci Rep. 2024; 14(1):28133.

PMID: 39548146 PMC: 11568293. DOI: 10.1038/s41598-024-76573-w.


Single-nuclei transcriptome analysis of channel catfish spleen provides insight into the immunome of an aquaculture-relevant species.

Aldersey J, Lange M, Beck B, Abernathy J PLoS One. 2024; 19(9):e0309397.

PMID: 39325796 PMC: 11426453. DOI: 10.1371/journal.pone.0309397.


Exhaustion of T cells after renal transplantation.

Wang X, Zhang J, Zhong P, Wei X Front Immunol. 2024; 15:1418238.

PMID: 39165360 PMC: 11333218. DOI: 10.3389/fimmu.2024.1418238.


TOX: a potential new immune checkpoint in cancers by pancancer analysis.

Qiu S, Lin W, Zhou Z, Hong Q, Chen S, Li J Discov Oncol. 2024; 15(1):354.

PMID: 39152366 PMC: 11329495. DOI: 10.1007/s12672-024-01236-1.


Single-nuclei sequencing of uterine serous carcinoma reveals racial differences in immune signaling.

Foley K, Adli M, Kim J Proc Natl Acad Sci U S A. 2024; 121(34):e2402998121.

PMID: 39133838 PMC: 11348309. DOI: 10.1073/pnas.2402998121.


References
1.
Scott A, Dundar F, Zumbo P, Chandran S, Klebanoff C, Shakiba M . TOX is a critical regulator of tumour-specific T cell differentiation. Nature. 2019; 571(7764):270-274. PMC: 7698992. DOI: 10.1038/s41586-019-1324-y. View

2.
Chen Y, Feng Z, Kuang X, Zhao P, Chen B, Fang Q . Increased lactate in AML blasts upregulates TOX expression, leading to exhaustion of CD8 cytolytic T cells. Am J Cancer Res. 2021; 11(11):5726-5742. PMC: 8640829. View

3.
Watkins E, Antane J, Roberts J, Lorentz K, Zuerndorfer S, Dunaif A . Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction. Sci Immunol. 2021; 6(56). DOI: 10.1126/sciimmunol.abe1801. View

4.
Lobbardi R, Pinder J, Martinez-Pastor B, Theodorou M, Blackburn J, Abraham B . TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia. Cancer Discov. 2017; 7(11):1336-1353. PMC: 5683427. DOI: 10.1158/2159-8290.CD-17-0267. View

5.
Han H, Jeong S, Kim H, Kim H, Kim A, Kwon M . TOX-expressing terminally exhausted tumor-infiltrating CD8 T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer. Cancer Lett. 2020; 499:137-147. DOI: 10.1016/j.canlet.2020.11.035. View